UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 108

Sortiert nach

Advances in respiratory virus therapeutics – A meeting report from the 6th isirv Antiviral Group conference

Antiviral research, 2019-07, Vol.167, p.45-67

2019

Volltextzugriff (PDF)

Impact of Baloxavir Resistance-Associated Substitutions on Influenza Virus Growth and Drug Susceptibility

Journal of virology, 2023-07, Vol.97 (7), p.e0015423-e0015423

2023

Volltextzugriff (PDF)

Most Influenza A Virions Fail To Express at Least One Essential Viral Protein

Journal of Virology, 2013-03, Vol.87 (6), p.3155-3162

2013

Volltextzugriff (PDF)

Influenza A virus hemagglutinin glycosylation compensates for antibody escape fitness costs

PLoS pathogens, 2018-01, Vol.14 (1), p.e1006796-e1006796

2018

Volltextzugriff (PDF)

Mutations in the Epidermal Growth Factor Receptor and in KRAS Are Predictive and Prognostic Indicators in Patients With Non–Small-Cell Lung Cancer Treated With Chemotherapy Alone and in Combination With Erlotinib

Journal of clinical oncology, 2005-09, Vol.23 (25), p.5900-5909

2005

Volltextzugriff (PDF)

Influenza A virus nucleoprotein selectively decreases neuraminidase gene-segment packaging while enhancing viral fitness and transmissibility

Proceedings of the National Academy of Sciences - PNAS, 2014-11, Vol.111 (47), p.16854-16859

2014

Volltextzugriff (PDF)

Reassortment Complements Spontaneous Mutation in Influenza A Virus NP and M1 Genes To Accelerate Adaptation to a New Host

Journal of Virology, 2013-04, Vol.87 (8), p.4330-4338

2013

Volltextzugriff (PDF)

Fitness costs limit influenza A virus hemagglutinin glycosylation as an immune evasion strategy

Proceedings of the National Academy of Sciences - PNAS, 2011-12, Vol.108 (51), p.E1417-E1422

2011

Volltextzugriff (PDF)

Defining Influenza A Virus Hemagglutinin Antigenic Drift by Sequential Monoclonal Antibody Selection

Cell host & microbe, 2013-03, Vol.13 (3), p.314-323

2013

Volltextzugriff (PDF)

Influenza A virus hemagglutinin mutations associated with use of neuraminidase inhibitors correlate with decreased inhibition by anti-influenza antibodies

Virology journal, 2019-11, Vol.16 (1), p.149-149, Article 149

2019

Volltextzugriff (PDF)

Suppression of Human Immunodeficiency Virus Type 1 (HIV-1) Viremia with Reverse Transcriptase and Integrase Inhibitors, CD4+ T-Cell Recovery, and Viral Rebound upon Interruption of Therapy in a New Model for HIV Treatment in the Humanized Rag2−/−γc−/− Mouse

Journal of Virology, 2009-08, Vol.83 (16), p.8254-8258

2009

Volltextzugriff (PDF)

Correction: Influenza A virus hemagglutinin glycosylation compensates for antibody escape fitness costs

PLoS pathogens, 2018-06, Vol.14 (6), p.e1007141-e1007141

2018

Volltextzugriff (PDF)

Evolution of the HIV-1 env Gene in the Rag2−/− γC−/− Humanized Mouse Model

Journal of Virology, 2010-03, Vol.84 (6), p.2740-2752

2010

Volltextzugriff (PDF)

Treatment-Emergent Influenza Virus Polymerase Acidic Substitutions Independent of Those at I38 Associated With Reduced Baloxavir Susceptibility and Virus Rebound in Trials of Baloxavir Marboxil

The Journal of infectious diseases, 2020-08, Vol.222 (6), p.957-961

2020

Volltextzugriff (PDF)

A Simple Flow-Cytometric Method Measuring B Cell Surface Immunoglobulin Avidity Enables Characterization of Affinity Maturation to Influenza A Virus

mBio, 2015-08, Vol.6 (4), p.e01156-e01156

2015

Volltextzugriff (PDF)

Greasing the SCIDs for Universal Flu Antibodies

Cell host & microbe, 2013-07, Vol.14 (1), p.7-8

2013

Volltextzugriff (PDF)

Biogenesis of influenza a virus hemagglutinin cross-protective stem epitopes

PLoS pathogens, 2014-06, Vol.10 (6), p.e1004204-e1004204

2014

Volltextzugriff (PDF)

Pleiotropic Effects of Influenza H1, H3, and B Baloxavir-Resistant Substitutions on Replication, Sensitivity to Baloxavir, and Interferon Expression

Antimicrobial agents and chemotherapy, 2022-04, Vol.66 (4), p.e0000922-e0000922

2022

Volltextzugriff (PDF)

Frameshifting to PA-X Influenza

Science (American Association for the Advancement of Science), 2012-07, Vol.337 (6091), p.164-165

2012

Volltextzugriff (PDF)

Major Coexisting Human Immunodeficiency Virus Type 1 env Gene Subpopulations in the Peripheral Blood Are Produced by Cells with Similar Turnover Rates and Show Little Evidence of Genetic Compartmentalization

Journal of Virology, 2009-05, Vol.83 (9), p.4068-4080

2009

Volltextzugriff (PDF)

Association of k-ras, b-raf, and p53 Status With the Treatment Effect of Bevacizumab

JNCI : Journal of the National Cancer Institute, 2005-07, Vol.97 (13), p.981-989

2005

Volltextzugriff (PDF)

Identification and recovery of minor HIV-1 variants using the heteroduplex tracking assay and biotinylated probes

Nucleic acids research, 2008-12, Vol.36 (22), p.e146

2008

Volltextzugriff (PDF)

Most Influenza A Virions Fail To Express at Least One Essential Viral Protein

Journal of virology, 2013-07, Vol.87 (14), p.8267-8267

2013

Volltextzugriff (PDF)

Biogenesis of Influenza A Virus Hemagglutinin Cross-Protective Stem Epitopes: e1004204

PLoS pathogens, 2014-06, Vol.10 (6)

2014

Volltextzugriff (PDF)

Evolution of the HIV-1 env Gene in the Rag2-/- C-/- Humanized Mouse Model

Journal of virology, 2010-03, Vol.84 (6), p.2740-2752

2010

Volltextzugriff (PDF)

1 – 25 von 108

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(77)

Publikationsform

Sprache

Englisch
(107)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Advances in respiratory virus therapeutics – A meeting report from the 6th isirv Antiviral Group conference

Impact of Baloxavir Resistance-Associated Substitutions on Influenza Virus Growth and Drug Susceptibility

Most Influenza A Virions Fail To Express at Least One Essential Viral Protein

Influenza A virus hemagglutinin glycosylation compensates for antibody escape fitness costs

Mutations in the Epidermal Growth Factor Receptor and in KRAS Are Predictive and Prognostic Indicators in Patients With Non–Small-Cell Lung Cancer Treated With Chemotherapy Alone and in Combination With Erlotinib

Influenza A virus nucleoprotein selectively decreases neuraminidase gene-segment packaging while enhancing viral fitness and transmissibility

Reassortment Complements Spontaneous Mutation in Influenza A Virus NP and M1 Genes To Accelerate Adaptation to a New Host

Fitness costs limit influenza A virus hemagglutinin glycosylation as an immune evasion strategy

Defining Influenza A Virus Hemagglutinin Antigenic Drift by Sequential Monoclonal Antibody Selection

Influenza A virus hemagglutinin mutations associated with use of neuraminidase inhibitors correlate with decreased inhibition by anti-influenza antibodies

Suppression of Human Immunodeficiency Virus Type 1 (HIV-1) Viremia with Reverse Transcriptase and Integrase Inhibitors, CD4+ T-Cell Recovery, and Viral Rebound upon Interruption of Therapy in a New Model for HIV Treatment in the Humanized Rag2−/−γc−/− Mouse

Correction: Influenza A virus hemagglutinin glycosylation compensates for antibody escape fitness costs

Evolution of the HIV-1 env Gene in the Rag2−/− γC−/− Humanized Mouse Model

Treatment-Emergent Influenza Virus Polymerase Acidic Substitutions Independent of Those at I38 Associated With Reduced Baloxavir Susceptibility and Virus Rebound in Trials of Baloxavir Marboxil

A Simple Flow-Cytometric Method Measuring B Cell Surface Immunoglobulin Avidity Enables Characterization of Affinity Maturation to Influenza A Virus

Greasing the SCIDs for Universal Flu Antibodies

Biogenesis of influenza a virus hemagglutinin cross-protective stem epitopes

Pleiotropic Effects of Influenza H1, H3, and B Baloxavir-Resistant Substitutions on Replication, Sensitivity to Baloxavir, and Interferon Expression

Frameshifting to PA-X Influenza

Major Coexisting Human Immunodeficiency Virus Type 1 env Gene Subpopulations in the Peripheral Blood Are Produced by Cells with Similar Turnover Rates and Show Little Evidence of Genetic Compartmentalization

Association of k-ras, b-raf, and p53 Status With the Treatment Effect of Bevacizumab

Identification and recovery of minor HIV-1 variants using the heteroduplex tracking assay and biotinylated probes

Most Influenza A Virions Fail To Express at Least One Essential Viral Protein

Biogenesis of Influenza A Virus Hemagglutinin Cross-Protective Stem Epitopes: e1004204

Evolution of the HIV-1 env Gene in the Rag2-/- C-/- Humanized Mouse Model

Suchergebnisse filtern